An impurity in the preparation of naratriptan
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

3,4-dihydro Naratriptan

Item No. 17890

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
N-methyl-3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indole-5-ethanesulfonamide
CAS Number
121679-20-7
Synonyms
  • Naratriptan Impurity B
Molecular Formula
C17H23N3O2S
Formula Weight
333.4
Purity
≥95%
Formulation (Request formulation change)
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 10 mg/mlDMF:PBS(pH 7.2)(1:1): 0.5 mg/mlDMSO: 10 mg/mlEthanol: 0.1 mg/ml
λmax
228, 260, 285 nm
SMILES
O=S(CCC1=CC=C2C(C(C3=CCN(C)CC3)=CN2)=C1)(NC)=O
InChi Code
InChI=1S/C17H23N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-5,11-12,18-19H,6-10H2,1-2H3
InChi Key
UJPMSESNMYEKDD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $130

    Add

    10 mg

    $247

    Add
    Product Description

    3,4-dihydro Naratriptan is an impurity formed during the preparation of naratriptan.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kumar, U.S., Sankar, V.R., Kumar, S.B., et al. An investigation into formation of impurity B during the optimization of naratriptan hydrochloride. Org. Process Res. Dev. 13, 468-470 (2009).